Therapeutic Area | MeSH |
---|---|
neoplasms | D009369 |
hemic and lymphatic diseases | D006425 |
immune system diseases | D007154 |
Brand Name | Status | Last Update |
---|---|---|
adcetris | Biologic Licensing Application | 2025-02-19 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hodgkin disease | — | D006689 | C81 |
large-cell lymphoma immunoblastic | — | D016400 | — |
Expiration | Code | ||
---|---|---|---|
brentuximab vedotin, Adcetris, Seagen Inc. | |||
2029-11-10 | Orphan excl. |
Code | Description |
---|---|
J9042 | Injection, brentuximab vedotin, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 4 | 7 | 3 | 3 | 9 | 23 |
Hodgkin disease | D006689 | — | C81 | 3 | 3 | 2 | 1 | 8 | 15 |
T-cell lymphoma | D016399 | — | — | 2 | 4 | — | 1 | 3 | 9 |
T-cell lymphoma peripheral | D016411 | — | — | 2 | 4 | — | 1 | 2 | 8 |
Large-cell lymphoma anaplastic | D017728 | — | C84.6 | 1 | 1 | — | 1 | 1 | 4 |
T-cell lymphoma cutaneous | D016410 | — | C84.A | — | — | — | 1 | 2 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | — | — | 1 | — | — | 1 |
B-cell lymphoma | D016393 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Extranodal nk-t-cell lymphoma | D054391 | — | C86.0 | 1 | 1 | — | — | — | 1 |
Enteropathy-associated t-cell lymphoma | D058527 | — | C86.2 | — | 1 | — | — | — | 1 |
Intestinal diseases | D007410 | — | K63.9 | — | 1 | — | — | — | 1 |
Drug common name | Brentuximab vedotin |
INN | brentuximab vedotin |
Description | Brentuximab Vedotin (chimeric mab) |
Classification | Antibody |
Drug class | synthetic analogs of the dolastatin series; monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1742994 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB08870 |
UNII ID | 7XL5ISS668 (ChemIDplus, GSRS) |